Pfizer’s Ruxience Rituximab Biosimilar Gets CHMP Nod

Positive Opinions Also Issued For Hybrids And Generics

 
• By David Wallace
  
Europe_Night
The CHMP Has Recommended Granting Pfizer A Pan-European Marketing Authorization • Source: Shutterstock

More from Biosimilars

More from Products